Given Imaging (Nasdaq: GIVN), which makes devices that deliver images of the gastrointestinal tract, on Monday said that sales for its devices were more than $3.2 million in the fourth quarter. This is significantly higher than projected, and represents 140% growth over the preceding period.
The Yoqneam, Israel-based company said almost half of the fourth quarter sales were in the United states. Given also said its sales for the year were more than $4.5 million.
The stock opened up 9% on Monday, but the generally dismal Nasdaq mood brought it down to a 5.5% gain later in the morning. At 11:00 am, the stock was trading at $16.30, while its 52-week high is $18.95.